| Melantha Dorthea Manns, MD | |
|
4500 13th Street, Gulfport, MS 39501 | |
| (228) 867-4396 | |
| (228) 867-5354 |
| Full Name | Melantha Dorthea Manns |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 18 Years |
| Location | 4500 13th Street, Gulfport, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750615076 | NPI | - | NPPES |
| 03442094 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 20915 (Mississippi) | Secondary |
| 207R00000X | Internal Medicine | 20915 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital At Gulfport | Gulfport, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Hospital At Gulfport | 2466524012 | 376 |
News Archive
The guidance, which is designed to help scientists avoid financial conflicts when conducting government-funded research, will take effect Aug. 24, 2012.
Anadis announced today its commercialization of a new product, BioGard, intended to maintain gastrointestinal and immune system health. The specific formulation may be of particular clinical benefit in persons undergoing antiretroviral therapy for HIV/AIDS.
Infertile men have an increased risk of developing high grade prostate cancer, which is more likely to grow and spread quickly. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The study's results suggest that because infertility may be an identifiable risk factor for prostate cancer, early screening may be warranted in infertile men.
Scientists from the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions New York University and the University of Florida today published a report detailing their new, more accurate method for identifying individual microbial species and strains in a community.
› Verified 9 days ago
| Entity Name | Keystone Medical Services Of Ms Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174691059 PECOS PAC ID: 7618075177 Enrollment ID: O20070606000447 |
News Archive
The guidance, which is designed to help scientists avoid financial conflicts when conducting government-funded research, will take effect Aug. 24, 2012.
Anadis announced today its commercialization of a new product, BioGard, intended to maintain gastrointestinal and immune system health. The specific formulation may be of particular clinical benefit in persons undergoing antiretroviral therapy for HIV/AIDS.
Infertile men have an increased risk of developing high grade prostate cancer, which is more likely to grow and spread quickly. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The study's results suggest that because infertility may be an identifiable risk factor for prostate cancer, early screening may be warranted in infertile men.
Scientists from the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions New York University and the University of Florida today published a report detailing their new, more accurate method for identifying individual microbial species and strains in a community.
› Verified 9 days ago
| Entity Name | Memorial Hospital At Gulfport |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215546635 PECOS PAC ID: 2466524012 Enrollment ID: O20090515000396 |
News Archive
The guidance, which is designed to help scientists avoid financial conflicts when conducting government-funded research, will take effect Aug. 24, 2012.
Anadis announced today its commercialization of a new product, BioGard, intended to maintain gastrointestinal and immune system health. The specific formulation may be of particular clinical benefit in persons undergoing antiretroviral therapy for HIV/AIDS.
Infertile men have an increased risk of developing high grade prostate cancer, which is more likely to grow and spread quickly. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The study's results suggest that because infertility may be an identifiable risk factor for prostate cancer, early screening may be warranted in infertile men.
Scientists from the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions New York University and the University of Florida today published a report detailing their new, more accurate method for identifying individual microbial species and strains in a community.
› Verified 9 days ago
| Entity Name | Keystone Hospitalist Services Of Ms Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932447968 PECOS PAC ID: 7517103864 Enrollment ID: O20130411000527 |
News Archive
The guidance, which is designed to help scientists avoid financial conflicts when conducting government-funded research, will take effect Aug. 24, 2012.
Anadis announced today its commercialization of a new product, BioGard, intended to maintain gastrointestinal and immune system health. The specific formulation may be of particular clinical benefit in persons undergoing antiretroviral therapy for HIV/AIDS.
Infertile men have an increased risk of developing high grade prostate cancer, which is more likely to grow and spread quickly. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The study's results suggest that because infertility may be an identifiable risk factor for prostate cancer, early screening may be warranted in infertile men.
Scientists from the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions New York University and the University of Florida today published a report detailing their new, more accurate method for identifying individual microbial species and strains in a community.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melantha Dorthea Manns, MD Po Box 1810, Gulfport, MS 39502 Ph: (228) 575-1194 | Melantha Dorthea Manns, MD 4500 13th Street, Gulfport, MS 39501 Ph: (228) 867-4396 |
News Archive
The guidance, which is designed to help scientists avoid financial conflicts when conducting government-funded research, will take effect Aug. 24, 2012.
Anadis announced today its commercialization of a new product, BioGard, intended to maintain gastrointestinal and immune system health. The specific formulation may be of particular clinical benefit in persons undergoing antiretroviral therapy for HIV/AIDS.
Infertile men have an increased risk of developing high grade prostate cancer, which is more likely to grow and spread quickly. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The study's results suggest that because infertility may be an identifiable risk factor for prostate cancer, early screening may be warranted in infertile men.
Scientists from the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions New York University and the University of Florida today published a report detailing their new, more accurate method for identifying individual microbial species and strains in a community.
› Verified 9 days ago
Dr. Nabil Azar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1340 Broad Ave, Suite 310, Gulfport, MS 39501 Phone: 228-575-1400 Fax: 228-575-1414 | |
Dr. Fahad Javed, M.D., Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4215 15th St, Gulfport, MS 39501 Phone: 228-863-5211 Fax: 228-863-4101 | |
Indrajit J Patel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-867-5201 Fax: 228-867-3152 | |
James K. Campbell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15190 Community Rd Ste 240, Gulfport, MS 39503 Phone: 228-575-7104 Fax: 228-539-6766 | |
Dr. Thomas Blanks, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1110 Broad Ave, Suite 700, Gulfport, MS 39501 Phone: 228-864-0314 Fax: 228-864-0425 | |
Dr. Stephanie Fussell, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1340 Broad Ave Ste 330, Gulfport, MS 39501 Phone: 228-575-1234 Fax: 228-867-4828 | |
Dr. Malcolm Scott Dean, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-867-5201 Fax: 228-867-3152 |